Extract
Mounting evidence of chronic obstructive and restrictive lung disease among respiratory tuberculosis (TB) patients after treatment [1–4], raises questions about current practice in terms of linkage to care once pharmacologic treatment for TB has stopped. A systematic review of post-TB chronic obstructive pulmonary disorder (COPD) showed pooled odds ratio (OR) of 3.05 (95% CI: 2.42–3.85) for people with a history of TB compared to non-TB controls [3]. Another review reported a range of proportions of TB patients with airflow obstruction post-TB to from 0.18–0.87 [1].
Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr. BASHAM reports grants from Canadian Institutes for Health Research, during the conduct of the study.
Conflict of interest: Dr. Cook has nothing to disclose.
Conflict of interest: Dr. JOHNSTON reports grants from Canadian Institutes for Health Research, and grants from the Michael Smith Foundation for Health Research during the conduct of the study.
- Received February 21, 2020.
- Accepted March 24, 2020.
- Copyright ©ERS 2020